Hsp27 Protein

Hsp27 Protein

Introduction

Hsp27 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Hsp27 (Heat Shock Protein 27, encoded by HSPB1) is a small heat shock protein with potent neuroprotective properties. It plays critical roles in protein quality control, cytoskeletal stabilization, and anti-apoptotic signaling in [neurons](/entities/neurons). [@ackerley2006]

Protein Information

<style> [@david2018]
.infobox { [@boncoraglio2012]
float: right;
width: 300px;
background: #f8f9fa;
border: 1px solid #ddd;
padding: 10px;
margin: 5px;
font-size: 0.9em;
}
.infobox th {
background: #28a745;
color: white;
padding: 5px;
text-align: left;
}
.infobox td {
padding: 3px 5px;
}
</style>

...

Hsp27 Protein

Introduction

Hsp27 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Hsp27 (Heat Shock Protein 27, encoded by HSPB1) is a small heat shock protein with potent neuroprotective properties. It plays critical roles in protein quality control, cytoskeletal stabilization, and anti-apoptotic signaling in [neurons](/entities/neurons). [@ackerley2006]

Protein Information

<style> [@david2018]
.infobox { [@boncoraglio2012]
float: right;
width: 300px;
background: #f8f9fa;
border: 1px solid #ddd;
padding: 10px;
margin: 5px;
font-size: 0.9em;
}
.infobox th {
background: #28a745;
color: white;
padding: 5px;
text-align: left;
}
.infobox td {
padding: 3px 5px;
}
</style>

<div class="infobox">
<table>
<tr><th colspan="2">Protein Summary</th></tr>
<tr><td>Name</td><td>Hsp27 (HSPB1)</td></tr>
<tr><td>Gene</td><td>HSPB1</td></tr>
<tr><td>UniProt ID</td><td>P04792</td></tr>
<tr><td>Molecular Weight</td><td>~27 kDa</td></tr>
<tr><td>Structure</td><td>Alpha-crystallin domain</td></tr>
<tr><td>Localization</td><td>Cytoplasm, nucleus</td></tr>
<tr><td>Family</td><td>Small Hsp family</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/fibrosis" style="color:#ef9a9a">Fibrosis</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">88 edges</a></td>
</tr>
</table>
</div>

Structure

Hsp27 is a 205-amino acid protein with:

• N-terminal domain: Contains the WDPF motif for oligomerization
• Alpha-crystallin domain: Conserved region shared with alpha-crystallins
• C-terminal region: Flexible tail involved in substrate binding

The protein forms large oligomers (12-24 subunits) that can dissociate into smaller active forms.

Normal Function

Molecular Chaperone

• Prevents protein aggregation under stress conditions
• Assists in refolding denatured proteins via Hsp70 cooperation
• Binds to unfolded proteins to maintain solubility

Cytoskeletal Stabilization

• Protects actin filaments from oxidative damage
• Maintains microtubule stability
• Preserves intermediate filament organization

Anti-Apoptotic Activity

• Inhibits cytochrome c release from mitochondria
• Blocks caspase activation cascade
• Modulates Bcl-2 family protein function

Axonal Transport

• Protects microtubule-based transport machinery
• Supports mitochondrial motility in axons
• Maintains synaptic vesicle trafficking

Role in Disease

Amyotrophic Lateral Sclerosis (ALS)

Hsp27 is downregulated in ALS spinal cord and motor [cortex](/brain-regions/cortex). Protective effects include:

• Reducing mutant SOD1 aggregation
• Supporting axonal transport
• Inhibiting motor neuron [apoptosis](/entities/apoptosis)

Charcot-Marie-Tooth Disease

HSPB1 mutations (R127W, S135F) cause CMT2F:

• Loss of chaperone function
• Impaired neuroprotection
• Distal axon degeneration

Alzheimer's Disease

Hsp27 levels correlate with disease progression:

• Neuroprotective against [Aβ](/proteins/amyloid-beta) toxicity
• Modulates [tau](/proteins/tau) phosphorylation
• Potential biomarker candidate

Parkinson's Disease

Hsp27 protects against:

• [Alpha-synuclein](/proteins/alpha-synuclein) aggregation
• Mitochondrial dysfunction
• Oxidative stress in dopaminergic neurons

Therapeutic Targeting

| Approach | Status | Description |
|----------|--------|-------------|
| Small molecule inducers | Preclinical | Arimoclomol, gemfibrozil upregulate Hsp27 |
| Gene therapy | Preclinical | AAV-HSPB1 delivery in models |
| Protein delivery | Research | Recombinant Hsp27 administration |

Key Publications

"Hsp27: a potential therapeutic target in ALS" - Neurobiology of Disease (2012) - PMID: 22024646(https://pubmed.ncbi.nlm.nih.gov/22024646/)](https://pubmed.ncbi.nlm.nih.gov/22024646/)

"Mutations in HSPB1 cause Charcot-Marie-Tooth disease type 2" - Nature Genetics (2004) - PMID: 15502946(https://pubmed.ncbi.nlm.nih.gov/15502946/)](https://pubmed.ncbi.nlm.nih.gov/15502946/)

"Hsp27 neuroprotection in [Alzheimer's disease](/diseases/alzheimers-disease)" - Journal of Alzheimer's Disease (2018) - PMID: 29504578(https://pubmed.ncbi.nlm.nih.gov/29504578/)](https://pubmed.ncbi.nlm.nih.gov/29504578/)

"Small [heat shock proteins](/entities/heat-shock-proteins) in neurodegeneration" - Acta Neuropathologica (2019) - PMID: 31069472(https://pubmed.ncbi.nlm.nih.gov/31069472/)](https://pubmed.ncbi.nlm.nih.gov/31069472/)

See Also

• [Proteins Index](/proteins)
• [HSPB1 Gene](/hspb1-gene)
• [Protein Quality Control Network](/mechanisms/protein-quality-control-network)
• [Motor Neurons](/cell-types/spinal-motor-neurons)
• [Synaptic Dysfunction Pathway](/mechanisms/synaptic-dysfunction-pathway)

External Links

• [UniProt: Hsp27](https://www.uniprot.org/uniprot/P04792)
• [PDB: 2N4J](https://www.rcsb.org/structure/2N4J)
• [HSPDB: Hsp27](https://life.nctu.edu.tw/hspdb/)

Background

The study of Hsp27 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Molecular Mechanism

Hsp27 (Heat Shock Protein 27, encoded by HSPB1) is a small heat shock protein (sHsp) that functions as a molecular chaperone with unique ATP-independent mechanism of action[@benndorf2001]. Unlike larger Hsp70/Hsp90 chaperones, Hsp27 forms large oligomers (12-32 subunits) that serve as a holding facility for misfolded proteins[@ackerley2006].

Structure and Oligomerization

Hsp27 contains an N-terminal α-crystallin domain and a C-terminal extension that mediates its dynamic oligomerization[@david2018]. The oligomeric state is regulated by phosphorylation at three serine residues (Ser15, Ser78, Ser82) by various kinases including MAPKAPK-2/3 and PKC[@boncoraglio2012].

Neuroprotective Functions

Anti-apoptotic Activity

Hsp27 directly inhibits caspase activation through multiple mechanisms:

• Stabilizes mitochondrial membrane potential
• Prevents cytochrome c release
• Inhibits apoptosome formation
• Directly binds to processed caspase-3[@c2004]

Cytoskeletal Protection

In neurons, Hsp27 protects the actin cytoskeleton from oxidative damage and maintains microtubule stability - critical for axonal transport[^6].

Role in Alzheimer's Disease

In AD, Hsp27 is upregulated in neurons surrounding amyloid plaques, suggesting a protective response against amyloid-β toxicity[^7]. Hsp27 can:

• Bind to Aβ peptides and reduce their aggregation
• Protect against Aβ-induced mitochondrial dysfunction
• Reduce caspase activation in vulnerable neurons

Role in Parkinson's Disease

Hsp27 protects dopaminergic neurons against:

• Oxidative stress (MPTP, 6-OHDA)
• Mitochondrial toxins
• α-synuclein toxicity[^8]

Polymorphisms in the HSPB1 gene have been associated with PD susceptibility in some populations.

Therapeutic Potential

Hsp27 represents a promising therapeutic target:

• Small molecule activators that upregulate Hsp27 expression
• Direct Hsp27 agonists that enhance its chaperone activity
• Cell-penetrating Hsp27 peptides for neuroprotection

References

Brain Atlas Resources

• [Allen Human Brain Atlas - Hsp27 Expression](https://human.brain-map.org/microarray/search/show?search_term=Hsp27)
• [Allen Cell Type Atlas - Hsp27](https://celltypes.brain-map.org/)
• [BrainSpan - Hsp27 Developmental Expression](https://brainspan.org/)
• [Allen Mouse Brain Atlas - Hsp27](https://mouse.brain-map.org/)

[@c2004]: C[^7]: Björkdahl, C. et al. [^8]: Zourlidou, A. et al. [Hsp27 and Parkinson's disease](https://pubmed.ncbi.nlm.nih.gov/15114008/). Neurology. 2004.